With a market cap of 122.67 B, Amgen Inc. has a large market cap size. Amgen Inc. (NASDAQ: AMGN) has been on the stock market since its IPO date on the 09/07/1984. Amgen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Amgen Inc., is 3363.14, and so far today it has a volume of 3043884. Performance year to date since the 09/07/1984 is 12.91%.
To help you determine whether Amgen Inc. is undervalued the following values will help you decide. P/E is 15.64 and forward P/E is 12.97. PEG perhaps more useful shows that Amgen Inc. has a value for PEG of 3.73. P/S ratio is 5.35 and the P/B ratio is 3.97. The P/Cash and P/Free cash flow is 3.19 and 17.82 respectively.
At the current price Amgen Inc. is trading at, 165.09 (1.64% today), Amgen Inc. has a dividend yield of 2.79%, and this is covered by a payout ratio of 39.00%. Earnings per share (EPS) is 10.56, and this is looking to grow in the next year to 2.37% after growing 13.10% this past year. EPS growth quarter over quarter is 11.80%, and -1.10% for sales growth quarter over quarter.
The number of shares outstanding is 743.05, and the number of shares float is 734.34. The senior management bring insider ownership to 0.20%, and institutional ownership is at 80.70%. The float short is 1.10%, with the short ratio at a value of 2.41. Management has seen a return on assets of 10.20%, and also a return on investment of 13.00%.
The ability for Amgen Inc., to deal with debt, means it current ratio is 4.4, and quick ratio is 4.1. Long term debt/equity is 0.99 and total debt/equity is 1.11. In terms of margins, Amgen Inc. has a gross margin of 81.90%, with its operating margin at 43.50%, and Amgen Inc. has a profit margin of 34.40%.
The 52 week high is -10.38%, with 23.53% being its 52 week low. The 20 day simple moving average is 3.76% and the 200 day simple moving average is 2.92%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.